ANIK
Anika Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$20.40
+4.88%Forward multiples
Based on analyst estimates
- P/E forward
- 21.70x
- P/E 2026E
- 19.21x
- P/E 2027E
- 21.23x
- P/E 2028E
- 17.54x
- P/S forward
- 2.18x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.99x
- Price / sales
- 2.26x
- Price / cash flow
- 45.68x
Enterprise value
- Enterprise value
- $257.9M
- EV / sales
- 2.14x
- EV / EBITDA
- 94.82x
- EV / EBIT
- -50.36x
- Market cap
- $273.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026